1. Home
  2. OLP vs EMBC Comparison

OLP vs EMBC Comparison

Compare OLP & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo One Liberty Properties Inc.

OLP

One Liberty Properties Inc.

HOLD

Current Price

$22.98

Market Cap

511.7M

Sector

Real Estate

ML Signal

HOLD

Logo Embecta Corp.

EMBC

Embecta Corp.

HOLD

Current Price

$3.05

Market Cap

524.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OLP
EMBC
Founded
1982
1924
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Medical/Dental Instruments
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
511.7M
524.1M
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
OLP
EMBC
Price
$22.98
$3.05
Analyst Decision
Strong Buy
Buy
Analyst Count
2
2
Target Price
$26.75
$18.50
AVG Volume (30 Days)
40.1K
3.2M
Earning Date
05-05-2026
05-05-2026
Dividend Yield
7.88%
6.88%
EPS Growth
N/A
20.90
EPS
0.28
0.67
Revenue
$82,740,000.00
N/A
Revenue This Year
$11.98
$1.17
Revenue Next Year
$3.71
N/A
P/E Ratio
$82.59
$4.54
Revenue Growth
1.02
N/A
52 Week Low
$19.62
$2.77
52 Week High
$25.90
$15.55

Technical Indicators

Market Signals
Indicator
OLP
EMBC
Relative Strength Index (RSI) 52.52 16.88
Support Level $22.36 N/A
Resistance Level $23.61 $9.51
Average True Range (ATR) 0.52 0.35
MACD -0.05 -0.18
Stochastic Oscillator 55.56 4.28

Price Performance

Historical Comparison
OLP
EMBC

About OLP One Liberty Properties Inc.

One Liberty Properties Inc is a self-administered and self-managed real estate investment trust. It acquires, owns, and manages a geographically diversified portfolio consisting mainly of industrial and, to a lesser extent, retail properties, many of which are subject to long-term net leases. The trust has approximately one hundred and two properties located across several states in the United States of America. A majority of its revenue is generated in the form of rental income.

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

Share on Social Networks: